Healthcare Sales & Marketing Network News: FGF-1

Searching News Database: FGF-1

HSMN NewsFeed - 31 Aug 2018
CardioVascular BioTherapeutics, Inc. Appoints Dr. David M. Ornitz and Dr. Arnold I. Chin to its Scientific and Medical Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2010
Phage Pharmaceuticals Appoints David Jackson as Vice President, Operations Planning
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
Biopharmaceuticals Wound Care

HSMN NewsFeed - 24 Apr 2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2007
CardioVascular BioTherapeutics Completes Phase I Wound Healing Trial
Biopharmaceuticals Wound Care

HSMN NewsFeed - 20 Sep 2007
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Biopharmaceuticals

HSMN NewsFeed - 10 Jul 2007
CardioVascular BioTherapeutics Authorized to Initiate Phase II Trial of Angiogenesis Therapy for Severe Coronary Heart Disease
Biopharmaceuticals Devices Drug Delivery Cardiology FDA

HSMN NewsFeed - 9 Jan 2007
U.S. Patent Office Allows CVBT's Patent Application for the Injection of FGF-1 Into the Human Heart
Regenerative Medicine Cardiology

HSMN NewsFeed - 17 Oct 2006
CardioVascular BioTherapeutics Elects Dr. Thomas Stegmann Co-President
Biopharmaceuticals Cardiology Personnel

Return to NewsFeed

Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 5 additional stories matching:
FGF-1
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.